IDXX

IDEXX LABORATORIES INC /DE

US StockNASDAQIn Vitro & In Vivo Diagnostic Substances

Research the business. Follow the filings.

Financial information from SEC disclosures, with reporting periods kept in context.

Revenue

4.3B USDAnnual · FY 2025

Operating income

1.4B USDAnnual · FY 2025

Net income

1.1B USDAnnual · FY 2025

Total assets

3.4B USDAnnual · FY 2025

Equity

1.6B USDAnnual · FY 2025

Operating cash flow

1.2B USDAnnual · FY 2025

IDXX · Chart

Chart provided by TradingView. Loading the chart connects your browser to TradingView and sends necessary technical information such as your IP address, page URL, and displayed symbol.

Reported financial information

Revenue

USD

4.3B USD

Period data
PeriodValue
FY 20213.2B USD
FY 20223.4B USD
FY 20233.7B USD
FY 20243.9B USD
FY 20254.3B USD

Operating income

USD

1.4B USD

Period data
PeriodValue
FY 2021932M USD
FY 2022898.8M USD
FY 20231.1B USD
FY 20241.1B USD
FY 20251.4B USD

Net income

USD

1.1B USD

Period data
PeriodValue
FY 2021744.8M USD
FY 2022679.1M USD
FY 2023845M USD
FY 2024887.9M USD
FY 20251.1B USD

Total assets

USD

3.4B USD

Period data
PeriodValue
FY 20212.4B USD
FY 20222.7B USD
FY 20233.3B USD
FY 20243.3B USD
FY 20253.4B USD

Equity

USD

1.6B USD

Period data
PeriodValue
FY 2021690M USD
FY 2022608.7M USD
FY 20231.5B USD
FY 20241.6B USD
FY 20251.6B USD

Operating cash flow

USD

1.2B USD

Period data
PeriodValue
FY 2021755.5M USD
FY 2022543M USD
FY 2023906.5M USD
FY 2024929M USD
FY 20251.2B USD

Revenue growth

%

10.4%

Period data
PeriodValue
FY 202118.8%
FY 20224.7%
FY 20238.7%
FY 20246.5%
FY 202510.4%

Operating income growth

%

20.5%

Period data
PeriodValue
FY 202134.2%
FY 2022-3.6%
FY 202322.1%
FY 20242.8%
FY 202520.5%

Net income growth

%

19.3%

Period data
PeriodValue
FY 202128%
FY 2022-8.8%
FY 202324.4%
FY 20245.1%
FY 202519.3%

Operating margin

%

31.6%

Period data
PeriodValue
FY 202129%
FY 202226.7%
FY 202330%
FY 202429%
FY 202531.6%

Net margin

%

24.6%

Period data
PeriodValue
FY 202123.2%
FY 202220.2%
FY 202323.1%
FY 202422.8%
FY 202524.6%

Return on assets

%

31.9%

Period data
PeriodValue
FY 202131.5%
FY 202226.2%
FY 202328.1%
FY 202427.1%
FY 202531.9%

Debt/Equity

x

1.09x

Period data
PeriodValue
FY 20212.53x
FY 20223.51x
FY 20231.2x
FY 20241.06x
FY 20251.09x